• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Bharat Biotech terminates deal with Brazil's Precisa to supply Covaxin

|
Google Oneindia News

Brasilia, July 23: Bharat Biotech has terminated a memorandum of understanding to sell its COVID-19 vaccine Covaxin to Precisa Medicamentos and Envixia Pharmaceuticals LL.C after graft allegations.

Representational Image

"The Company has terminated the said MOU with immediate effect. Notwithstanding such termination, Bharat Biotech will continue to work diligently with ANVISA, the Brazilian drug regulatory body to complete the regulatory approval process for Covaxin," it said.

Bharat Biotech is pursuing approvals in various countries as per legal requirements applicable in each country, it said.

Bharat Biotech signed a MoU with Precisa Medicamentos and Envixia Pharmaceuticals LL.C on November 20 for the purpose of introducing Covaxin in the territory of Brazil.

The global pricing of the vaccine has been set between USD 15-20 and accordingly, the jab was offered to the Government of Brazil at the rate of USD 15 per dose, Bharat Biotech said.

It is further stated that the company has not received any advance payments from, nor has it supplied any vaccines to the Ministry of Health in Brazil, the company said.

The vaccine maker stressed that all its actions, including its global dealings, are done in accordance with local laws and the company employs and follows the highest standards of ethics, integrity and compliance at all times.

For Daily Alerts
Best Deals and Discounts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X